SCHEMBL770192

SCHEMBL770192

O=C(CCCC(=O)N1CCCC2CCCCC21)NCCc1c[nH]c2ccc(O)cc12

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 10/20 0.58
SPR P35270 4/20 0.54
FAAH O00519 1/20 0.52
PTGS2 P35354 1/20 0.52
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
MAPT P10636 1/20 0.50
IDO1 P14902 1/20 0.50
HPGD P15428 1/20 0.50
BLM P54132 1/20 0.50
NOTUM Q6P988 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
BCHE P06276 1/20 0.49
ACHE P22303 1/20 0.49
MTNR1A P48039 1/20 0.47
MTNR1B P49286 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL770772 0.88 MTNR1A (0.65) TRPV1KDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL15229781 0.87 SPR (0.50) SPRKDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL770465 0.80 DPP4 (0.45) TRPV1KDM4EMAPT
SCHEMBL771003 0.78 BCHE (0.43) TRPV1SPRKDM4EALDH1A1CYP1A2
SCHEMBL19051471 0.78 TRPV1 (0.76) TRPV1SPRFAAHPTGS2KDM4E
SCHEMBL15245439 0.77 MPO (0.56) NOTUMMTNR1AMTNR1B
SCHEMBL15245288 0.77 HTR1D (0.50) ALDH1A1MAPTHPGDMTNR1AMTNR1B
SCHEMBL15245300 0.77 SNCA (0.47) MTNR1AMTNR1B
SCHEMBL25137286 0.76 TRPV1 (0.76) TRPV1SPRFAAHPTGS2KDM4E
SCHEMBL15245679 0.76 ALDH1A1 (0.64) KDM4EALDH1A1MAPTHPGDMTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2439202-B1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 SALVAT LAB SA (ES) 2016-04-20 EP disclosed
US-8822452-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2014-09-02 US disclosed
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2013-11-14 US disclosed
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2013-11-14 US disclosed
US-8524894-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2013-09-03 US disclosed
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2012-03-22 US disclosed
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303522-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 TRPV1 4299/4885SPR 904/4885FAAH 184/4885
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 TRPV1 4311/4885SPR 887/4885FAAH 187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.